Study S001998

Dual Glucose-dependent Insulinotropic Peptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in Women With Obesity for Frozen Embryo Transfer (FET): Pragmatic, Multicenter, Randomized Controlled Trial

ClinicalTrials.gov record

Registration

Registration: NCT07811895
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 1510
Start: 2026-09
Primary completion: 2029-12
Lead sponsor: RenJi Hospital
Conditions: Tirzepatide; Frozen Embryo Transfer; Obesity
Interventions: DRUG:Dual GIP/GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Good birth outcome rate [at delivery]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.